CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Takahashi, Masayuki
Daizumoto, Kei
Fukuhara, Yayoi
Ozaki, Keisuke
Tsuda, Megumi
Kusuhara, Yoshito
Mori, Hidehisa
Fukawa, Tomoya
Yamamoto, Yasuyo
Yamaguchi, Kunihisa
Fukumori, Tomoharu
Kanayama, Hiroomi
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP72-06
引用
收藏
页码：E954 / E954
页数：1
相关论文
共 50 条
  • [21] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG.
    Ameratunga, Malaka
    Broad, Adam
    Pavlakis, Nick
    Gebski, Val
    Khasraw, Mustafa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1189 - S1189
  • [22] Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors
    Johnston, Hartlee
    Deal, Allison M.
    Morgan, Katherine P.
    Patel, Bianka
    Milowsky, Matthew I.
    Rose, Tracy L.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : 357 - 365
  • [23] Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
    Subramanian, Janakiraman
    Morgensztern, Daniel
    Govindan, Ramaswamy
    CLINICAL LUNG CANCER, 2010, 11 (05) : 311 - 319
  • [24] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Ghatalia, Pooja
    Morgan, Charity
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Langer, CJ
    Natale, RB
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S23 - S29
  • [26] Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma
    Parker, AS
    Cheville, JC
    Lohse, C
    Cerhan, JR
    Blute, ML
    JOURNAL OF UROLOGY, 2003, 170 (02): : 420 - 424
  • [27] Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma
    Go, Heounjeong
    Kang, Mun Jung
    Kim, Pil-Jong
    Lee, Jae-Lyun
    Park, Ji Y.
    Park, Ja-Min
    Ro, Jae Y.
    Cho, Yong Mee
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 51 - 58
  • [28] The continuing role of epidermal growth factor receptor tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung
    Tan, Wan Ling
    Ng, Quan-Sing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 106 - 109
  • [29] Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
    Bielecka, Zofia F.
    Czarnecka, Anna M.
    Solarek, Wojciech
    Kornakiewicz, Anna
    Szczylik, Cezary
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2013, 8 (03) : 219 - 228
  • [30] IDENTIFICATION OF THE KDR TYROSINE KINASE AS A RECEPTOR FOR VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR
    TERMAN, BI
    DOUGHERVERMAZEN, M
    CARRION, ME
    DIMITROV, D
    ARMELLINO, DC
    GOSPODAROWICZ, D
    BOHLEN, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (03) : 1579 - 1586
12345